Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
› Fosphenytoin sodium (Pro-Epanutin ): serious arrhythmias and hypotension
› Focus on: the Safety of Medicines for Children
› Local skin reactions to amethocaine (Ametop)
› Safety of malathion for the treatment of louse and scabies infestation
› Pumactant (ALEC): voluntary withdrawal by the manufacturer
› Lamotrigine (Lamictal): revised dose for children
› Lamotrigine (Lamictal): rare blood dyscrasias
› Medication error: potential for confusing Humalog and Humalog Mix 05
› Danthron restricted to constipation in the terminally ill
› Breast and pelvic examination in women taking oral contraceptives
› Reteplase (Rapilysin ): incompatibility with heparin
› Reminder: St John's Wort (Hypericum perforatum) interactions
› When you see the black triangle
Current Problems in Pharmacovigilance May 2000 
